Can we define and develop targeted therapies for obese asthma subgroups?
Asthma is a chronic disease affecting 25 millions people, including 6 million children. Our vision is to advance the field of asthma for specific subgroups with novel therapies at the individual level and with specific approaches at the system level.
We seek to define the drivers of asthma, develop therapies and customized approaches targeting lifestyle and behavioral factors absent from current asthma guidelines. Our specific focus will be on obese asthma patients who are prone to more severe, worse outcomes and are at an increased risk of hospitalization and a lower quality of life.
Asthma Research and Precision Medicine
Questions we're asking that inform us on how to best care for patients include:
Which innovation strategies can be applied to improve adherence to asthma therapy?
Do personalized approaches for environmental modifications reduce asthma morbidity and potentially prevent disease?
Patient Care for Asthma
Johns Hopkins Allergy & Asthma Center
5501 Hopkins Bayview Circle
Baltimore, MD 21224
Research Program Manager